FDA Inspection 1046908 — National Institutes Of Health IRB
The FDA completed an inspection of National Institutes Of Health IRB on Jan 25, 2018 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bethesda, MD (United States)
Additional Details
IRB